A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics and Safety of Digoxin in Healthy Volunteers.
Condition(s):HealthyLast Updated:November 19, 2012Completed
Hide Studies Not Open or Pending
Condition(s):HealthyLast Updated:November 19, 2012Completed
Condition(s):Arrhythmia; ECG Changes; HypotensionLast Updated:September 26, 2013Unknown status
Condition(s):EpilepsyLast Updated:June 19, 2018Completed
Condition(s):Heart FailureLast Updated:December 12, 2023Active, not recruiting
Condition(s):Polycythemia; Familial; Erythrocytosis; Familial; VHL Gene Mutation; HIF-2alpha Erythrocytosis; PHD2 Erythrocytosis; Chuvash ErythrocytosisLast Updated:June 13, 2023Withdrawn
Condition(s):Healthy VolunteersLast Updated:August 29, 2016Completed
Condition(s):AbortionLast Updated:October 30, 2019Completed
Condition(s):Type 2 Diabetes MellitusLast Updated:January 5, 2011Completed
Condition(s):MelanomaLast Updated:May 15, 2018Completed
Condition(s):Healthy; HIV InfectionsLast Updated:April 7, 2011Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.